The diagnosis of HPP includes observance of characteristic symptoms, measurement of decreased serum AP activity (based on age- and sex-specific reference values), detection of increased PLP concentrations in the blood serum [42], as well as phosphoethanolamine (PEA) in the urine, and the detection of mutations in the ALPL gene sequence [43]. This evidence concerns the gene ALPL and hypophosphatasia.